Pages that link to "Q41912121"

The following pages link to PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance. (Q41912121):

Displaying 21 items.

• Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4. (Q36259221) (← links)
• Should Gleason 6 be labeled as cancer? (Q36931932) (← links)
• Clinical and molecular rationale to retain the cancer descriptor for Gleason score 6 disease (Q39023426) (← links)
• PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER. (Q39108592) (← links)
• ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression. (Q43269413) (← links)
• Molecular mechanisms involving prostate cancer racial disparity (Q45327318) (← links)
• Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer (Q47215343) (← links)
• Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes (Q47436732) (← links)
• Clinical implications of PTEN loss in prostate cancer (Q49818398) (← links)
• Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer (Q49964150) (← links)
• Molecular Biomarkers in the Clinical Management of Prostate Cancer (Q50133991) (← links)
• Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer. (Q52645860) (← links)
• The future of active surveillance. (Q55445309) (← links)
• Molecular correlates of intermediate- and high-risk localized prostate cancer (Q57109051) (← links)
• Transcriptomic heterogeneity in multifocal prostate cancer (Q58617291) (← links)
• Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer (Q90139206) (← links)
• Cancer overdiagnosis: a biological challenge and clinical dilemma (Q91524608) (← links)
• Contemporary approach to active surveillance for favorable risk prostate cancer (Q91808461) (← links)
• Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications (Q92316366) (← links)
• MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity (Q97587462) (← links)
• Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype (Q98471360) (← links)